Evidence map›Paper›PMID 41799383›Full record

ArticleFrontiers in pharmacology2025

Historical texts as a potential resource for plant-based antiviral agents against SARS-CoV-2: the example of the Receptarium of Burkhard III von Hallwyl from 16th-century Switzerland.

Nina Vahekeni, Jonas Stehlin, Corinna Urmann, Evelyn Wolfram, Yannick Geissmann, Yelena Ruedin, Samuel Peter, Olivier Engler, Andreas Lardos

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Dentistry journal · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nina VahekeniNatural Product Chemistry and Phytopharmacy Group, School of Life Sciences and Facility Management, Institute of Chemistry and Biotechnology, ZHAW Zurich University of Applied Sciences, Wädenswil, Switzerland.
Jonas StehlinNatural Product Chemistry and Phytopharmacy Group, School of Life Sciences and Facility Management, Institute of Chemistry and Biotechnology, ZHAW Zurich University of Applied Sciences, Wädenswil, Switzerland.
Corinna UrmannOrganic-Analytical Chemistry, Weihenstephan-Triesdorf University of Applied Sciences, Straubing, Germany.
Evelyn WolframNatural Product Chemistry and Phytopharmacy Group, School of Life Sciences and Facility Management, Institute of Chemistry and Biotechnology, ZHAW Zurich University of Applied Sciences, Wädenswil, Switzerland.
Yannick GeissmannSpiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
Yelena RuedinSpiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
Samuel PeterNatural Product Chemistry and Phytopharmacy Group, School of Life Sciences and Facility Management, Institute of Chemistry and Biotechnology, ZHAW Zurich University of Applied Sciences, Wädenswil, Switzerland.
Olivier EnglerSpiez Laboratory, Federal Office for Civil Protection, Spiez, Switzerland.
Andreas LardosNatural Product Chemistry and Phytopharmacy Group, School of Life Sciences and Facility Management, Institute of Chemistry and Biotechnology, ZHAW Zurich University of Applied Sciences, Wädenswil, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In search for effective prophylactic and possibly curative therapeutics against SARS-CoV-2, an historical-ethnopharmacological approach was used to select plants described in the Receptarium of Burkhard III von Hallwyl (RBH), a recipe text from 16th century Switzerland. Ten plant species were selected from the pre-established RBH database based on specific historical uses presumably linked with the treatment of viral infections. Methods: From each plant aqueous and hydroethanolic extracts were produced. CellTiter-Glo® Luminescent Cell Viability Assay was used to assess antiviral activity against SARS-CoV-2 and the effect on cell viability of the extracts. Results: Of the ten plants tested, four displayed an antiviral activity ≥ 50% at 16.7 μg/ml with acceptable cell viability (> 75%): Conclusions: Our study suggests that an ethnopharmacological approach based on historical records of plant use in combination with a rational selection and testing procedure allows to identify interesting candidates, even among medicinal plants no longer in use. The process of selecting plants from RBH also illustrates the challenges associated with the study of historical texts, particularly the interpretation of the medicinal uses and the assessment of the botanical identities of historical plant names.

Indexed as

ethnopharmacologyGeranium robertianummedicinal plantsSARS-CoV-2vero cells E6Viola odorata

Identifiers

PMID41799383
PMCPMC12960544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.